European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Prebiotics and impact on resilience to circadian rhythms disruptions September 20, 2021 Effects of Synbiotics in Improving Type 2 Diabetes Mellitus Markers February 18, 2025 Synbiotic Approach to Immunity and Metabolism in the Elderly December 2, 2020